Logo-aim
Arch Iran Med. 2023;26(2): 100-109.
doi: 10.34172/aim.2023.16
PMID: 37543930
PMCID: PMC10685899
  Abstract View: 824
  PDF Download: 541

Original Article

Potential of Autologous Adipose-Derived Mesenchymal Stem Cells in Peritoneal Fibrosis: A Pilot Study

Amin Ahmadi 1,2 ORCID logo, Reza Moghadasali 1, Iraj Najafi 3, Soroosh Shekarchian 4, Sudabeh Alatab 5* ORCID logo

1 Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
2 Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
3 Nephrology Research Center, Shariati Hospital, Tehran University of Medical sciences, Tehran, Iran
4 Maastricht University Medical Center, Maastricht, Limburg, Netherlands
5 Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Sudabeh Alatab, Email: sudabehalatab@yahoo.com

Abstract

Background: We aimed to determine the effects of systemic therapy with autologous adipose tissue derived mesenchymal stem cells (AD-MSCs) on different parameters of peritoneal function and inflammation in peritoneal dialysis (PD) patients.

Methods: We enrolled nine PD patients with ultrafiltration failure (UFF). Patients received 1.2±0.1×106 cell/kg of AD-MSCs via cubital vein and were then followed for six months at time points of baseline, 3, 6, 12, 16 and 24 weeks after infusion. UNI-PET was performed for assessment of peritoneal characteristics at baseline and weeks 12 and 24. Systemic and peritoneal levels of tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), IL-2 and CA125 (by ELISA) and gene expression levels of transforming growth factor beta (TGF-β), smooth muscle actin (𝛼-SMA) and fibroblast-specific protein-1 (FSP-1) in PD effluent derived cells (by quantitative real-time PCR) were measured at baseline and weeks 3, 6, 12, 16 and 24.

Results: Slight improvement was observed in the following UF capacity indices: free water transport (FWT, 32%), ultrafiltration - small pore (UFSP, 18%), ultrafiltration total (UFT, 25%), osmotic conductance to glucose (OCG, 25%), D/P creatinine (0.75 to 0.70), and Dt/D0 glucose (0.23 to 0.26). There was a slight increase in systemic and peritoneal levels of CA125 and a slight decrease in gene expression levels of TGF-β, α-SMA and FSP-1 that was more prominent at week 12 and vanished by the end of the study.

Conclusion: Our results for the first time showed the potential of MSCs for treatment of peritoneal damage in a clinical trial. Our results could be regarded as hypothesis suggestion and will need confirmation in future studies.


Cite this article as: Ahmadi A, Moghadasali R, Najafi I, Ahmadbeigi N, Shekarchian S, Alatab S. Potential of autologous adipose-derived mesenchymal stem cells in peritoneal fibrosis: A pilot study. Arch Iran Med. 2023;26(2):100-109. doi: 10.34172/aim.2023.16
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 825

Your browser does not support the canvas element.


PDF Download: 541

Your browser does not support the canvas element.

Submitted: 03 Apr 2022
Accepted: 01 Jan 2023
ePublished: 01 Feb 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)